Doctor profile · Federal record
Dr. Stephen Werth, M.D.
Dermatology Physician (CMS: Dermatology) · Quincy, MA
- NPI 1093762734
- Accepts Medicare
- 41 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
300 Congress St, Suite 408
Quincy, MA 021690907
(617) 773-7431
fax (617) 773-9592
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- November 6, 2015
- Year of graduation
- 1985 — 41 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Massachusetts #73556
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1093762734. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
5,498
Distinct HCPCS
10
Medicare allowed
$469,289
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,798 | 1,521 | $99 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,408 | 327 | $8 | |
17000 |
Destruction of precancer skin growth, 1 growth | 603 | 530 | $64 | |
11102 |
Biopsy of related skin growth, first growth | 446 | 384 | $114 | |
11103 |
Biopsy of related skin growth, each additional growth | 259 | 121 | $58 | |
17110 |
Destruction of skin growth, 1-14 growths | 123 | 117 | $130 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 122 | 122 | $123 | |
12032 |
Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 101 | 92 | $336 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 101 | 86 | $140 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 72 | 52 | $156 |
In context: peer comparison
Among 4 peers in Quincy Dermatology Physician, average services per provider: 150. This provider delivers 37× the peer median.Open Payments
Industry payments received
All-time total
$414
Transactions
16
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 3 | $79.15 | |
| Pfizer INC. | 2 | $57.89 | |
| Genzyme Corporation | 1 | $49.08 | |
| Dermavant Sciences, INC. | 2 | $43.50 | |
| Sandoz INC. | 2 | $42.20 | |
| Arcutis Biotherapeutics, INC. | 2 | $39.59 | |
| Leo Pharma INC. | 1 | $30.00 | |
| Sun Pharmaceutical Industries INC. | 1 | $25.71 | |
| Regeneron Healthcare Solutions, INC. | 1 | $24.93 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $22.41 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,415
Patients
690
Total drug cost
$1,022,226
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Betamethasone Dipropionate | Generic | 175 | 80 | $8,799 |
| Fluorouracil | Generic | 159 | 141 | $12,304 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 153 | 89 | $10,384 |
| Ketoconazole | Generic | 138 | 70 | $2,575 |
| Triamcinolone Acetonide | Generic | 135 | 86 | $2,061 |
| Metronidazole | Generic | 99 | 48 | $6,171 |
| Methotrexate (Methotrexate Sodium) | Brand | 95 | 19 | $2,208 |
| Gabapentin | Generic | 93 | 23 | $1,162 |
| Hydroxychloroquine Sulfate | Generic | 60 | 0 | $2,116 |
| Doxycycline Hyclate | Generic | 57 | 25 | $1,421 |
Frequently asked questions
What is Dr. Stephen Werth's medical specialty?
Dr. Stephen Werth practices Dermatology Physician in Quincy, MA.
Where does Dr. Stephen Werth practice?
Dr. Stephen Werth practices at 300 Congress St, Quincy, MA 021690907. Office phone: 6177737431.
What is Dr. Stephen Werth's NPI?
Dr. Stephen Werth's National Provider Identifier (NPI) is 1093762734, issued by NPPES.
Does Dr. Stephen Werth accept Medicare assignment?
Yes. Dr. Stephen Werth accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Stephen Werth commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.